
Becky Bish
@Becky_ABC
Followers
653
Following
3K
Media
76
Statuses
445
Identifying and accelerating high impact cancer research at @TheMarkFdn
New York
Joined May 2012
RT @TheMarkFdn: 📢Funding Opportunity!📢 The Mark Foundation is now accepting letters of intent for the Endeavor Award. ✅$3 million in cance….
themarkfoundation.org
0
2
0
The annual #AACR25 meeting gets more exciting every year, as the footprint of @TheMarkFdn funded researchers grows. Check out our grantees' presentations here - including Cathy Wu presenting her Endeavor team's cancer vaccines in the plenary now!
themarkfoundation.org
The American Association for Cancer Research (AACR) Annual Meeting is a cornerstone event for the cancer research community, bringing together leading minds in the field to share the latest…
0
1
11
RT @TheMarkFdn: 📢 Funding Opportunity! 📢. The Mark Foundation is now accepting letters of intent for the Emerging Leader Award. ✅$750,000….
themarkfoundation.org
0
2
0
RT @TheMarkFdn: How can we accelerate the development of effective cell and gene therapies for #GBM patients? Last week at #ACGT25, The Mar….
0
1
0
RT @TheMarkFdn: 📢We’re hiring a Grants & Data Operations Coordinator!📢. Are you experienced in database management, project coordination, o….
0
3
0
RT @TheMarkFdn: Interested in applying for an Endeavor Award? We will begin accepting Letters of Intent for our next funding round on June….
themarkfoundation.org
0
2
0
RT @Rndubois: #AACR CEO Marge Foti speaks at #recalcitrant #cancers meeting in Philly: For the first time ever, three organizations come t….
0
3
0
RT @TheMarkFdn: The end of the year is approaching! Make your tax-deductible donation to the Mark Foundation before December 31st and suppo….
0
2
0
RT @TheMarkFdn: Are molecular glue degraders having their moment?. In @biospace, Mark Foundation CEO Ryan Schoenfeld shares why he thinks w….
biospace.com
Novartis, Biogen, Takeda and Novo Nordisk are all betting on advances in the molecular glue degraders space, collectively investing billions in hopes of treating cancer, Alzheimer’s disease, cardio...
0
1
0
RT @TheMarkFdn: We’re in Boston for the 1st annual meeting of the @CancerGrand Challenges MATCHMAKERS team! The team, which we sponsor with….
0
4
0
RT @CSHL: The CSHL School of Biological Sciences is celebrating its 25th anniversary! To mark this milestone, we spoke with 5 of its gradua….
cshl.edu
Research is itself an educational activity. With the laws of science and nature for teachers, researchers conduct experiments to learn how life and the world work. Cold Spring Harbor Laboratory...
0
2
0
RT @sontagfdn: We are excited to share that The Brain Tumor Funders' Collaborative is now accepting applications for innovative brain tumor….
0
2
0
#SNO2024 is the perfect follow up for @TheMarkFdn @sontagfdn glioblastoma workshop - reconnecting with attendees and going in depth in so many important topics in brain cancer
0
0
14
RT @sontagfdn: The #Glioblastoma workshop with @TheMarkFdn was incredible! Thank you to everyone who attended. We’re inspired by the collab….
0
4
0
RT @IlonLiu: Thank you so much to the @sbtfoundation @TheMarkFdn @sontagfdn for this wonderful award and opportunity to join the workshop w….
0
2
0
RT @sontagfdn: A great final day at the #glioblastoma workshop with the @TheMarkFdn. We heard from many presenters including David Ashley a….
0
2
0
RT @SaraGMP: It was an incredible meeting! Thanks to @TheMarkFdn @sontagfdn and the organizers for the invitation. Two days of outstanding….
0
2
0
RT @BcellBruno: I was so honored to be selected to take part in this important initiative. It was such an interactive and informative coupl….
0
1
0
RT @TyMillerLab: So privileged to be in a room for a couple days with this incredible group of physicians/scientists who are leading brain….
0
1
0
Fantastic @TheMarkFdn @sontagfdn workshop on glioblastoma - bringing together 41 of the top researchers in brain tumors & therapeutics from around the world to figure out how to beat this devastating disease. @sheilasinghlab @kaelin_lab & Tim Cloughesy are fantastic organizers
0
2
32